Logo image of ZTS

ZOETIS INC (ZTS) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ZTS - US98978V1035 - Common Stock

124.65 USD
-0.63 (-0.5%)
Last: 1/16/2026, 8:04:00 PM
124.596 USD
-0.05 (-0.04%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to ZTS. ZTS was compared to 190 industry peers in the Pharmaceuticals industry. ZTS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ZTS has a decent growth rate and is not valued too expensively. ZTS also has an excellent dividend rating. These ratings could make ZTS a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year ZTS was profitable.
  • ZTS had a positive operating cash flow in the past year.
  • In the past 5 years ZTS has always been profitable.
  • Each year in the past 5 years ZTS had a positive operating cash flow.
ZTS Yearly Net Income VS EBIT VS OCF VS FCFZTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

  • With an excellent Return On Assets value of 17.49%, ZTS belongs to the best of the industry, outperforming 96.32% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 49.11%, ZTS belongs to the top of the industry, outperforming 97.89% of the companies in the same industry.
  • ZTS has a Return On Invested Capital of 21.45%. This is amongst the best in the industry. ZTS outperforms 96.84% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZTS is significantly above the industry average of 12.84%.
Industry RankSector Rank
ROA 17.49%
ROE 49.11%
ROIC 21.45%
ROA(3y)16.01%
ROA(5y)14.94%
ROE(3y)49.01%
ROE(5y)47.06%
ROIC(3y)21.64%
ROIC(5y)19.86%
ZTS Yearly ROA, ROE, ROICZTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • ZTS has a better Profit Margin (28.21%) than 93.68% of its industry peers.
  • In the last couple of years the Profit Margin of ZTS has grown nicely.
  • ZTS's Operating Margin of 38.25% is amongst the best of the industry. ZTS outperforms 96.84% of its industry peers.
  • In the last couple of years the Operating Margin of ZTS has grown nicely.
  • With a decent Gross Margin value of 71.71%, ZTS is doing good in the industry, outperforming 78.42% of the companies in the same industry.
  • ZTS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.25%
PM (TTM) 28.21%
GM 71.71%
OM growth 3Y0.39%
OM growth 5Y2.44%
PM growth 3Y0.84%
PM growth 5Y2.31%
GM growth 3Y0.03%
GM growth 5Y0.65%
ZTS Yearly Profit, Operating, Gross MarginsZTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

  • ZTS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for ZTS has been reduced compared to 1 year ago.
  • ZTS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZTS is higher compared to a year ago.
ZTS Yearly Shares OutstandingZTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
ZTS Yearly Total Debt VS Total AssetsZTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

  • An Altman-Z score of 6.43 indicates that ZTS is not in any danger for bankruptcy at the moment.
  • ZTS has a Altman-Z score of 6.43. This is in the better half of the industry: ZTS outperforms 77.37% of its industry peers.
  • ZTS has a debt to FCF ratio of 3.16. This is a good value and a sign of high solvency as ZTS would need 3.16 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 3.16, ZTS belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
  • A Debt/Equity ratio of 1.31 is on the high side and indicates that ZTS has dependencies on debt financing.
  • The Debt to Equity ratio of ZTS (1.31) is worse than 75.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.16
Altman-Z 6.43
ROIC/WACC2.33
WACC9.22%
ZTS Yearly LT Debt VS Equity VS FCFZTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • ZTS has a Current Ratio of 3.64. This indicates that ZTS is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.64, ZTS is in line with its industry, outperforming 56.32% of the companies in the same industry.
  • A Quick Ratio of 2.28 indicates that ZTS has no problem at all paying its short term obligations.
  • ZTS's Quick ratio of 2.28 is in line compared to the rest of the industry. ZTS outperforms 47.89% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 2.28
ZTS Yearly Current Assets VS Current LiabilitesZTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 10.07% over the past year.
  • The Earnings Per Share has been growing by 10.22% on average over the past years. This is quite good.
  • ZTS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.68%.
  • The Revenue has been growing by 8.14% on average over the past years. This is quite good.
EPS 1Y (TTM)10.07%
EPS 3Y8%
EPS 5Y10.22%
EPS Q2Q%7.59%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y5.98%
Revenue growth 5Y8.14%
Sales Q2Q%0.5%

3.2 Future

  • ZTS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.88% yearly.
  • ZTS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.67% yearly.
EPS Next Y8.15%
EPS Next 2Y7.44%
EPS Next 3Y7.99%
EPS Next 5Y7.88%
Revenue Next Year2.07%
Revenue Next 2Y3.51%
Revenue Next 3Y4.23%
Revenue Next 5Y4.67%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZTS Yearly Revenue VS EstimatesZTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
ZTS Yearly EPS VS EstimatesZTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 19.66, ZTS is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of ZTS indicates a rather cheap valuation: ZTS is cheaper than 82.63% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, ZTS is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 18.24, which indicates a rather expensive current valuation of ZTS.
  • ZTS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ZTS is cheaper than 78.42% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.26. ZTS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.66
Fwd PE 18.24
ZTS Price Earnings VS Forward Price EarningsZTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ZTS is valued cheaply inside the industry as 82.63% of the companies are valued more expensively.
  • 83.16% of the companies in the same industry are more expensive than ZTS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.52
EV/EBITDA 14.74
ZTS Per share dataZTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ZTS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.41
PEG (5Y)1.92
EPS Next 2Y7.44%
EPS Next 3Y7.99%

7

5. Dividend

5.1 Amount

  • ZTS has a Yearly Dividend Yield of 1.64%.
  • ZTS's Dividend Yield is rather good when compared to the industry average which is at 0.35. ZTS pays more dividend than 92.11% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, ZTS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • On average, the dividend of ZTS grows each year by 21.42%, which is quite nice.
  • ZTS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ZTS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)21.42%
Div Incr Years11
Div Non Decr Years11
ZTS Yearly Dividends per shareZTS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • ZTS pays out 32.55% of its income as dividend. This is a sustainable payout ratio.
  • ZTS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.55%
EPS Next 2Y7.44%
EPS Next 3Y7.99%
ZTS Yearly Income VS Free CF VS DividendZTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
ZTS Dividend Payout.ZTS Dividend Payout, showing the Payout Ratio.ZTS Dividend Payout.PayoutRetained Earnings

ZOETIS INC

NYSE:ZTS (1/16/2026, 8:04:00 PM)

After market: 124.596 -0.05 (-0.04%)

124.65

-0.63 (-0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-04
Earnings (Next)02-12
Inst Owners97.58%
Inst Owner Change0.63%
Ins Owners0.06%
Ins Owner Change0.11%
Market Cap54.93B
Revenue(TTM)9.40B
Net Income(TTM)2.65B
Analysts79.17
Price Target163.06 (30.81%)
Short Float %2.47%
Short Ratio2.09
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend1.73
Dividend Growth(5Y)21.42%
DP32.55%
Div Incr Years11
Div Non Decr Years11
Ex-Date01-20
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.77%
Min EPS beat(2)3.79%
Max EPS beat(2)7.75%
EPS beat(4)4
Avg EPS beat(4)5.09%
Min EPS beat(4)3.63%
Max EPS beat(4)7.75%
EPS beat(8)7
Avg EPS beat(8)3.39%
EPS beat(12)10
Avg EPS beat(12)3.67%
EPS beat(16)12
Avg EPS beat(16)2.98%
Revenue beat(2)1
Avg Revenue beat(2)-0.16%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)1.11%
Revenue beat(4)2
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)6
Avg Revenue beat(12)0.2%
Revenue beat(16)7
Avg Revenue beat(16)-0.15%
PT rev (1m)-4.08%
PT rev (3m)-16.56%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)-6.21%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)-0.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.5%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE 19.66
Fwd PE 18.24
P/S 5.85
P/FCF 24.52
P/OCF 18.84
P/B 10.18
P/tB 34.46
EV/EBITDA 14.74
EPS(TTM)6.34
EY5.09%
EPS(NY)6.83
Fwd EY5.48%
FCF(TTM)5.08
FCFY4.08%
OCF(TTM)6.62
OCFY5.31%
SpS21.32
BVpS12.25
TBVpS3.62
PEG (NY)2.41
PEG (5Y)1.92
Graham Number41.8
Profitability
Industry RankSector Rank
ROA 17.49%
ROE 49.11%
ROCE 26.92%
ROIC 21.45%
ROICexc 25.41%
ROICexgc 38.35%
OM 38.25%
PM (TTM) 28.21%
GM 71.71%
FCFM 23.84%
ROA(3y)16.01%
ROA(5y)14.94%
ROE(3y)49.01%
ROE(5y)47.06%
ROIC(3y)21.64%
ROIC(5y)19.86%
ROICexc(3y)27.73%
ROICexc(5y)26.47%
ROICexgc(3y)50.54%
ROICexgc(5y)50.93%
ROCE(3y)27.16%
ROCE(5y)24.93%
ROICexgc growth 3Y2.53%
ROICexgc growth 5Y2.14%
ROICexc growth 3Y5.51%
ROICexc growth 5Y8.06%
OM growth 3Y0.39%
OM growth 5Y2.44%
PM growth 3Y0.84%
PM growth 5Y2.31%
GM growth 3Y0.03%
GM growth 5Y0.65%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.16
Debt/EBITDA 1.73
Cap/Depr 138.24%
Cap/Sales 7.19%
Interest Coverage 12.22
Cash Conversion 71.42%
Profit Quality 84.5%
Current Ratio 3.64
Quick Ratio 2.28
Altman-Z 6.43
F-Score6
WACC9.22%
ROIC/WACC2.33
Cap/Depr(3y)135.63%
Cap/Depr(5y)123.22%
Cap/Sales(3y)7.63%
Cap/Sales(5y)7.16%
Profit Quality(3y)74.77%
Profit Quality(5y)82.34%
High Growth Momentum
Growth
EPS 1Y (TTM)10.07%
EPS 3Y8%
EPS 5Y10.22%
EPS Q2Q%7.59%
EPS Next Y8.15%
EPS Next 2Y7.44%
EPS Next 3Y7.99%
EPS Next 5Y7.88%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y5.98%
Revenue growth 5Y8.14%
Sales Q2Q%0.5%
Revenue Next Year2.07%
Revenue Next 2Y3.51%
Revenue Next 3Y4.23%
Revenue Next 5Y4.67%
EBIT growth 1Y7.7%
EBIT growth 3Y6.4%
EBIT growth 5Y10.78%
EBIT Next Year16.84%
EBIT Next 3Y9.66%
EBIT Next 5Y7.94%
FCF growth 1Y50.13%
FCF growth 3Y9.8%
FCF growth 5Y11.47%
OCF growth 1Y32.73%
OCF growth 3Y10.09%
OCF growth 5Y10.47%

ZOETIS INC / ZTS FAQ

What is the ChartMill fundamental rating of ZOETIS INC (ZTS) stock?

ChartMill assigns a fundamental rating of 7 / 10 to ZTS.


Can you provide the valuation status for ZOETIS INC?

ChartMill assigns a valuation rating of 6 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.


How profitable is ZOETIS INC (ZTS) stock?

ZOETIS INC (ZTS) has a profitability rating of 9 / 10.


Can you provide the expected EPS growth for ZTS stock?

The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 8.15% in the next year.


Is the dividend of ZOETIS INC sustainable?

The dividend rating of ZOETIS INC (ZTS) is 7 / 10 and the dividend payout ratio is 32.55%.